Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Clinical significance of the immunohistochemical profile of ovarian endometrioid cysts

Тезиков Y. В., Стрижаков А. Н., Липатов И. С., Калинкина О. Б., Аравина О. Р., Мартyнова Н. В.
Акушерство и гинекология
Т. 2020, Вып. 2, С. 116-124
Опубликовано: 2020
Тип ресурса: Статья

DOI:10.18565/aig.2020.2.116-124

Аннотация:
Objective. To identify the immunohistochemical (IHC) phenotypes on the basis of the representation of molecular markers in the endometrioid ovarian cyst (EOC) capsule (EOCC) in order to justify a differentiated approach to therapy and to reduce relapse rates. Subjects and methods. To identify the features of the IHC profile of EOCC (the expression of estrogen and progesterone receptors, Ki-67, p53) and to estimate the impact of personalized anti-relapse therapy after surgical treatment, the investigators examined 170 women with EOC, who formed three comparison groups: 1) 50 women who received anti-relapse treatment with regard to the IHC profile of EOCC; 2) 80 women who had hormone therapy after the surgical stage of treatment without regard to the IHC phenotype; 3) 40 women who refused subsequent hormone therapy after surgical treatment. Control endometrial samples were taken from 25 healthy women. Results. Four IHC phenotypes of EOCC were identified. A differentiated approach to trea
Ключевые слова:
Endometrioid ovarian cysts; Estrogen and progesterone receptors; Immunohistochemical analysis; Ki-67; P53; Personalized treatment; Relapse rate
estrogen receptor; Ki 67 antigen; progesterone receptor; protein p53; Article; clinical feature; controlled study; female; hormonal therapy; human; human tissue; immunohistochemistry; major clinical study; outcome assessment; ovarian endometrioid cyst; ovary cyst; phenotype
Язык текста: Русский
ISSN: 0300-9092
Тезиков Y. В.
Стрижаков А. Н. Александр Николаевич 1937-
Липатов И. С.
Калинкина О. Б.
Аравина О. Р.
Мартyнова Н. В.
Tezikov Y. V.
Strizhakov A. N. Aleksandr Nikolaevich 1937-
Lipatov I. S.
Kalinkina O. B.
Aravina O. R.
Martynova N. V.
Clinical significance of the immunohistochemical profile of ovarian endometrioid cysts
Текст визуальный непосредственный
Акушерство и гинекология
Бионика Медиа
Т. 2020, Вып. 2 С. 116-124
2020
Статья
Endometrioid ovarian cysts Estrogen and progesterone receptors Immunohistochemical analysis Ki-67 P53 Personalized treatment Relapse rate
estrogen receptor Ki 67 antigen progesterone receptor protein p53 Article clinical feature controlled study female hormonal therapy human human tissue immunohistochemistry major clinical study outcome assessment ovarian endometrioid cyst ovary cyst phenotype
Objective. To identify the immunohistochemical (IHC) phenotypes on the basis of the representation of molecular markers in the endometrioid ovarian cyst (EOC) capsule (EOCC) in order to justify a differentiated approach to therapy and to reduce relapse rates. Subjects and methods. To identify the features of the IHC profile of EOCC (the expression of estrogen and progesterone receptors, Ki-67, p53) and to estimate the impact of personalized anti-relapse therapy after surgical treatment, the investigators examined 170 women with EOC, who formed three comparison groups: 1) 50 women who received anti-relapse treatment with regard to the IHC profile of EOCC; 2) 80 women who had hormone therapy after the surgical stage of treatment without regard to the IHC phenotype; 3) 40 women who refused subsequent hormone therapy after surgical treatment. Control endometrial samples were taken from 25 healthy women. Results. Four IHC phenotypes of EOCC were identified. A differentiated approach to trea